<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Gamida Cell Ltd.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Gamida Cell Ltd.

    Gamida Cell is a clinical-stage biopharmaceutical company committed to developing novel cell therapies with the potential to cure difficult-to-treat cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based cell expansion technology, or NAM technology, to develop product candidates designed to address the limitations of cell therapies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $165,000,000
    • SIC CODE
      2636
    • NIN CODE
      ####
    • LEADERSHIP
      Julian Adams, Ph.D.
    • FOUNDED
      1998
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Akibah Health Corporation

    Akibah Health Corporation

    GluCase is an all-in-one diabetes management system that seamlessly integrates a g...

    GluCase is an all-in-one diabetes management sy...

    Amount Raised:    $38,481.00
    Fundraising Status:    EC
    Filing Type:    CF
    Liquidia Technologies, Inc.

    Liquidia Technologies, Inc.

    Liquidia is a late-stage clinical biopharmaceutical company focused on the develop...

    Liquidia is a late-stage clinical biopharmaceut...

    Filing Type:    PU
    FreshMynd Inc.

    FreshMynd Inc.

    Freshmynd is developing a breakthrough ADHD supplement for kids backed by 20+ inde...

    Freshmynd is developing a breakthrough ADHD sup...

    Amount Raised:    $58,475.00
    Fundraising Status:    EC
    Filing Type:    CF
    Vascular Biogenics Ltd.

    Vascular Biogenics Ltd.

    VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharm...

    VBL Therapeutics is a publicly traded (NASDAQ: ...

    Filing Type:    PU
    Merus N.V.

    Merus N.V.

    Merus is a clinical-stage immuno-oncology company developing innovative full-lengt...

    Merus is a clinical-stage immuno-oncology compa...

    Filing Type:    PU
    Orgenesis Inc.

    Orgenesis Inc.

    Orgenesis is a vertically-integrated biopharmaceutical company with unique experti...

    Orgenesis is a vertically-integrated biopharmac...

    Filing Type:    PU
    CytomX Therapeutics, Inc.

    CytomX Therapeutics, Inc.

    CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...

    CytomX Therapeutics develops Probody™ therape...

    Filing Type:    PU
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Unum Therapeutics Inc.

    Unum Therapeutics Inc.

    Unum Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Unum Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    ©2024 National Investor Network. All Rights Reserved.